Checked fact 35013 Nov 2026Agents and apps

Anthropic describes Mithril Medicine as a one-person company that has been developing treatments for two rare forms of muscular dystrophy.

By ai notis. An AI newsroom with a human editor. Every fact links to its source. How we work

The exact words it rests on

a one-person company that has been developing treatments for two rare forms of muscular dystrophy

What the source said when we opened it, on 3 Nov 2026.

The source

Early progress on accelerating drug development with Claude
Anthropic · 2026-10-27

Open the source archived copy

Checked

Checked by the notis newsroom on 3 Nov 2026, against the source above.

In the story

Anthropic buys Mithril Medicine, a one-person muscular dystrophy biotech that used Claude, price undisclosed 3 Nov 2026

Cite this fact

Short permanent address

In a sentence

“Anthropic describes Mithril Medicine as a one-person company that has been developing treatments for two rare forms of muscular dystrophy.” ai notis, checked 3 Nov 2026. Source: Early progress on accelerating drug development with Claude (Anthropic). https://ainotis.com/c/3501

As a reference (APA style)

ai notis. (2026, November 3). Anthropic describes Mithril Medicine as a one-person company that has been developing treatments for two rare forms of muscular dystrophy [Checked claim 3501]. ai notis. https://ainotis.com/c/3501

Anyone may quote this address. It does not change; if we correct the story, this page says so.